The proton pump inhibitor test for gastroesophageal reflux disease: Optimal cut-off value and duration

Digestive and Liver Disease

Volumn 42, Issue 11, 2010, Pages 785-790

  de Leone, Annalisa ^a   Tonini, Marcello ^b   Dominici, Patrizia ^c   Grossi, Enzo ^c   Pace, Fabio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c Bracco Imaging SpA   (Italy)

Author keywords

Diagnostic tests; Esophagus; GERD; Symptom score or index

Indexed keywords

OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ESOPHAGITIS; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; REFLUX ESOPHAGITIS; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; TREATMENT RESPONSE;

ADULT; DRUG ADMINISTRATION SCHEDULE; ESOPHAGEAL PH MONITORING; ESOPHAGITIS; ESOPHAGOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMANS; ITALY; MALE; MIDDLE AGED; OMEPRAZOLE; PROSPECTIVE STUDIES; PROTON PUMP INHIBITORS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77955234570     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.04.002     Document Type: Article

References (42)

1. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastroesophageal reflux disease: a systematic review. Gut 2005, 54:710-717.
2. Savarino V., Celle G. The outcome of reflux oesophagitis: does drug-induced remission mean cure?. Ital J Gastroenterol Hepatol 1998, 30:475-477.
3. Spechler S.J. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992, 51(Suppl. 1):24-29.
4. Tytgat G.N.J. Long-term therapy for reflux esophagitis. N Engl J Med 1995, 333:1148-1150.
5. Dent J., Brun J., Fendrick A.M., et al. An evidence-based appraisal of reflux disease management-the Genval Workshop Report. Gut 1999, 44(Suppl. 2):S1-S16.
6. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006, 101:1900-1920.
7. Modlin I.M., Hunt R.H., Malfetheiner P., et al. Diagnosis and management of non-erosive reflux disease-the Vevey NERD Consensus Group. Digestion 2009, 80:74-88.
8. Venables T.L., Newland R.D., Patel A.C., et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of gastrooesophageal reflux disease in general practice. Scand J Gastroenterol 1997, 32:965-973.
9. Pandolfino J.E., Vela M.F. Esophageal-reflux monitoring. Gastrointest Endosc 2009, 69:917-930.
10. Pohl D., Tutuian R. Reflux monitoring: pH-metry, Bilitec and Oesophageal impedance measurements. Best Pract Res Clin Gastroenterol 2009, 23:299-311.
11. Schindlbeck N.E., Klauser A.G., Voderholzer W.A., et al. Empiric therapy for gastroesophageal reflux disease. Arch Intern Med 1995, 155:1808-1812.
12. Chiba N., De Gara C.J., Wilkinson J.M., et al. Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997, 112:1798-1810.
13. Bruley des Varannes S., Levy P., Lartigue S., et al. Comparison of lansoprazole with omeprazole on 24-hour intragastric pH, acid secretion and serum gastrin in healthy volunteers. Aliment Pharmacol Ther 1994, 8:309-314.
14. Fass R., Fennerty M.B., Ofman J.J., et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998, 115:42-49.
15. Fass R., Ofman J.J., Sampliner R.E., et al. The omeprazole test is as sensitive as 24-h oesophageal pH monitoring in diagnosing gastro-oesophageal reflux disease in symptomatic patients with erosive oesophagitis. Aliment Pharmacol Ther 2000, 14:389-396.
16. Savary M., Miller G. The esophagus: handbook and atlas of endoscopy 1978, Verlag Gassman, Solothurn (Switzerland), pp. 119-59.
17. Fass R., Ofman J.J., Gralnek I.M., et al. Clinical and economic assessment of the omeprazole test in patients with symptoms suggestive of gastroesophageal reflux disease. Arch Intern Med 1999, 159:2161-2168.
18. Ofman J.J., Gralnek I.M., Udani J., et al. The cost-effectiveness of the omeprazole test in patients with noncardiac chest pain. Am J Med 1999, 107:219-227.
19. Bate C.M., Riley S.A., Chapman R.W., et al. Evaluation of omeprazole as a cost-effective diagnostic test for gastro-oesophageal reflux disease. Aliment Pharmacol Ther 1999, 13:59-66.
20. Johnsson F., Weywadt L., Solhaug J.H., et al. One-week omeprazole treatment in the diagnosis of gasto-oesophageal reflux disease. Scand J Gastroenterol 1998, 33:15-20.
21. Metz D.C., Childs M.L., Ruiz C., et al. Pilot study of the oral omeprazole test for reflux laryngitis. Otolaryngol Head Neck Surg 1997, 116:41-46.
22. Schenk B.E., Kuipers E.J., Klinkenberg-Knol E.C., et al. Omeprazole as a diagnostic tool in gastro-esophageal reflux disease. Am J Gastroenterol 1997, 92:1997-2000.
23. Moayyedi P., Talley N. Gastro-esophageal reflux disease. Lancet 2006, 367:2086-2100.
24. Joseph S., Hirano I. Gastroesophageal reflux disease: diagnosis. GERD/dyspepsia: hot topics 2004, 41-54. Hanley & Belfus, Philadelphia, PA. R. Fass (Ed.).
25. Boyle J.T. Gastroesophageal reflux disease in 2006. The imperfect diagnosis. Pediatr Radiol 2006, 36(Suppl. 2):192-195.
26. Euler A., Byrne W. Twenty-four-hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology 1981, 80:957-961.
27. Richter J., Castell D.O. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy. Ann Intern Med 1982, 97:93-103.
28. Behar J., Biancani P., Sheahan D. Evaluation of esophageal tests in the diagnosis of reflux esophagitis. Gastroenterology 1976, 71:9-15.
29. Martinez S.D., Malagon I.B., Garewal H.S., et al. Non-erosive reflux disease (NERD)-acid reflux and symptom patterns. Aliment Pharmacol Ther 2003, 17:537-545.
30. des Varannes S.B., Mion F., Ducrottè P., et al. Simultaneous recording of oesophageal acid exposure with conventional pH monitoring and a wireless system (Bravo). Gut 2005, 54:1682-1686.
31. Kuipers E.J., Klinkeberg-Knol E.C., Jansen E.H., et al. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Gastroenterology 1995, 108:A137.
32. Juul-Hansen P., Ryding A., Jacobsen C., et al. High-dose proton-pump inhibitors as a diagnostic test of gastro-esophageal reflux disease in endoscopic-negative patients. Scand J Gastroenterol 2001, 36:806-810.
33. Xu G., Fang Y., Cheng N., et al. Diagnostic value of Omeprazole test in gastro-esophageal reflux disease. Chin J Dig 2002, 22:7-10.
34. des Varannes S.B., Sacher-Huvelin S., Vavasseur F., et al. Rabeprazole test for the diagnosis of gastro-oesophageal reflux disease: results of a study in a primary care setting. World J Gastroenterol 2006, 28:2569-2573.
35. Ho K.Y., Gwee K.A., Khor C.J., et al. Empirical treatment for the management of patients presenting with uninvestigated reflux symptoms: a prospective study in an Asian primary care population. Aliment Pharmacol Ther 2005, 21:1313-1320.
36. Numans M.E., Lau J., de Wit N.J., et al. Short-term treatment with proton-pump inhibitors as a test for Gastroesophageal reflux disease: a meta-analysis of diagnostic test characteristics. Ann Intern Med 2004, 140:518-527.
37. Aanen M.C., Weusten B.L.A.M., Numans M.E., et al. Diagnostic value of the proton pump inhibitor test for gastro-oesophageal reflux disease in primary care. Aliment Pharmacol Ther 2006, 24:1377-1384.
38. Santalucia F., Pace F., Sangaletti O., et al. Usefulness and limitation of 24 h oesophageal pH-monitoring as an ambulatory technique in the diagnosis of gastro-oesophageal reflux. Eur J Gastroenterol Hepatol 1992, 4:1001-1006.
39. Savarino V., Di Mario F., Scarpignato C. Proton pump inhibitors in GORD. An overview of their pharmacology, efficacy and safety. Pharmacol Res 2009, 59:135-153.
40. Johnsson F., Hatlebakk J.G., Klinterberg A.C., et al. One-week esomeprazole treatment: an effective confirmatory test in patients with suspected gastroesophageal reflux disease. Scand J Gastroenterol 2003, 38:354-359.
41. Dean B.B., Gano A.D., Knight K., et al. Effectiveness of proton pump inhibitors in nonerosive reflux disease. Clin Gastroenterol Hepatol 2004, 2:656-664.
42. Savarino E., Zentilin P., Tutuian R., et al. The role of nonacid reflux in NERD: lessons learned from impedance-pH monitoring in 150 patients off therapy. Am J Gastroenterol 2008, 103:2685-2693.